Location
Turner Gymnasium
Access Type
Campus Access Only
Presentation Type
Printed poster
Entry Number
2335
Start Date
4-16-2025 12:00 PM
End Date
4-16-2025 1:15 PM
School
School of Medicine and Health Sciences
Department
Nursing
Keywords
Diabetes, Insulin, Insulin cost, Socioeconomic class, Insurance, Diabetes management
Abstract
Issues for individuals with Diabetes in lower socioeconomic backgrounds affect the ability to access insulin consistently and affordably. Through the analysis of peer reviewed articles and scientific studies we will expose social class differences and show the relationship between this data and the ability of low-income diabetic patients to access insulin. Research shows that a person who has a lower income has to work four to seven days to buy just 10 mL of insulin. The literature reveals that uninsured Americans with Diabetes are more likely to be using less effective and cheaper formulas of insulin, compared to people in the upper-class, or with private insurance. Not having consistent access to insulin ultimately leads to poor management of diabetes, which affects other areas of health. The goal of our research is to look specifically into trends that pertain to obstructions in receiving insulin products due to socioeconomic components and to propose goals for the reduction of the barriers to accessing insulin. Diabetes does not discriminate, and one’s access to insulin is heavily dependent on socioeconomic status. Individuals may not be aware of available resources to help receive insulin. When insulin is not used consistently or properly, poor disease management presents as other health issues that have the potential to require additional medication attention. Solutions must be found to combat these barriers of accessing insulin.
Primary Faculty Mentor(s)
Susan Braud, DNP, RN, CCRN
Primary Faculty Mentor(s) Department
Nursing
Rights Statement
The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.
Chronic Disease Management: Self-Management Strategies for Diabetes: Evaluating the effectiveness of various self-management techniques and educational programs
Turner Gymnasium
Issues for individuals with Diabetes in lower socioeconomic backgrounds affect the ability to access insulin consistently and affordably. Through the analysis of peer reviewed articles and scientific studies we will expose social class differences and show the relationship between this data and the ability of low-income diabetic patients to access insulin. Research shows that a person who has a lower income has to work four to seven days to buy just 10 mL of insulin. The literature reveals that uninsured Americans with Diabetes are more likely to be using less effective and cheaper formulas of insulin, compared to people in the upper-class, or with private insurance. Not having consistent access to insulin ultimately leads to poor management of diabetes, which affects other areas of health. The goal of our research is to look specifically into trends that pertain to obstructions in receiving insulin products due to socioeconomic components and to propose goals for the reduction of the barriers to accessing insulin. Diabetes does not discriminate, and one’s access to insulin is heavily dependent on socioeconomic status. Individuals may not be aware of available resources to help receive insulin. When insulin is not used consistently or properly, poor disease management presents as other health issues that have the potential to require additional medication attention. Solutions must be found to combat these barriers of accessing insulin.